Omega-3 用于 皮质醇相关体重增加
C 证据 来自小型研究的证据有限,但存在一些积极信号。Omega-3 supplementation may modulate HPA axis response to stress. Small RCTs show reduced cortisol response during mental stress tests. Anti-inflammatory effects may reduce cortisol-driven visceral fat inflammation.
结论
Omega-3 supplementation may modulate HPA axis response to stress. Small RCTs show reduced cortisol response during mental stress tests. Anti-inflammatory effects may reduce cortisol-driven visceral fat inflammation.
Key Study Findings
研究人群: Patients with acne, HS, or psoriasis
研究人群: None
研究人群: None
研究人群: Patients with rheumatoid arthritis
研究人群: Older adults with sarcopenia (review)
研究人群: DNBS-induced Crohn's disease BALB/c mouse model
Key Statistics
5
研究数量
300
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 250-500 mg EPA+DHA/day
- antiinflammatory:
- 2,000-4,000 mg/day
- weightmanagement:
- 1,000-3,000 mg EPA+DHA/day
上限: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| 50, 100, and 200 mg/kg oral | -- | Positive | -- |
| None | -- | Mixed | -- |
| High-dose EPA or DHA | -- | Positive | -- |
最佳服用时间: With meals containing fat for absorption; may split dose AM/PM
Safety & Side Effects
已报告的副作用
- ⚠ Fishy aftertaste
- ⚠ GI discomfort
- ⚠ Increased bleeding time (at high doses)
- ⚠ Nausea
已知相互作用
- ● Blood thinners (may enhance anticoagulant effect at high doses)
- ● Blood pressure medications (additive effect)
- ● Orlistat (reduced absorption)
可耐受最高摄入量: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Omega-3 help with 皮质醇相关体重增加?
How much Omega-3 should I take for 皮质醇相关体重增加?
Are there side effects of Omega-3?
How strong is the evidence for Omega-3 and 皮质醇相关体重增加?
Related Evidence
其他成分用于 皮质醇相关体重增加
References
- [1] Riya Gautam Naik et al.. Nutrients. 2025. From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management. doi:10.3390/nu17030470 PubMed
- [2] Anshika Malhotra et al.. J Am Nutr Assoc. 2025. Analytical Review on Nutritional Deficiencies in Vegan Diets: Risks, Prevention, and Optimal Strategies. doi:10.1080/27697061.2025.2461218 PubMed
- [3] Larissa Parreira Araújo et al.. Int J Mol Sci. 2025. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. doi:10.3390/ijms262412147 PubMed
- [4] Mohamed Sofiane Merakeb et al.. J Ethnopharmacol. 2025. Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. (flaxseed) in vivo. doi:10.1016/j.jep.2025.120001 PubMed
- [5] Luigi Barrea et al.. Curr Obes Rep. 2025. Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), … doi:10.1007/s13679-025-00630-2 PubMed
- [6] Maria Polyzou et al.. Nutrients. 2025. The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive Review. doi:10.3390/nu17243826 PubMed
- [7] Jacques D Barth. Atherosclerosis. 2025. The omega effect: Harnessing fish oil for health. doi:10.1016/j.atherosclerosis.2025.120461 PubMed
- [8] R Poggioli et al.. Eur Rev Med Pharmacol Sci. 2023. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in … doi:10.26355/eurrev_202308_33310 PubMed
- [9] Angélica Borja-Magno et al.. Front Nutr. 2023. Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid … doi:10.3389/fnut.2023.1156995 PubMed
- [10] Rosa María Martínez García et al.. Nutr Hosp. 2021. [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. doi:10.20960/nh.03800 PubMed
- [11] Robert Carreras-Torres et al.. Sci Rep. 2020. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. doi:10.1038/s41598-020-76361-2 PubMed
- [12] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
- [13] A Jaca et al.. S Afr Med J. 2020. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. doi:10.7196/SAMJ.2020.v110i12.14730 PubMed
- [14] Amy Locke et al.. Am Fam Physician. 2018. Diets for Health: Goals and Guidelines. PubMed
- [15] Tim Y Hou et al.. Eur J Pharmacol. 2016. Omega-3 fatty acids, lipid rafts, and T cell signaling. doi:10.1016/j.ejphar.2015.03.091 PubMed
- [16] K Kaliannan et al.. Int J Obes (Lond). 2016. Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity. doi:10.1038/ijo.2016.27 PubMed
- [17] Meagen McCusker et al.. Clin Dermatol. 2016. Nutrition and skin: Kids are not just little people. doi:10.1016/j.clindermatol.2016.07.004 PubMed
- [18] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed
- [19] Owen J Kelly et al.. Nutr Res. 2013. Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. doi:10.1016/j.nutres.2013.04.012 PubMed
- [20] Mi-Kyung Sung et al.. World J Gastroenterol. 2013. Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. doi:10.3748/wjg.v19.i7.994 PubMed
- [21] Parris M Kidd. Altern Med Rev. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. PubMed
- [22] Devendra K Amre et al.. Am J Gastroenterol. 2007. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. doi:10.1111/j.1572-0241.2007.01411.x PubMed
- [23] Aneta Aleksandra Nielsen et al.. Digestion. 2007. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin … doi:10.1159/000101560 PubMed
- [24] R M Hackman et al.. Int J Obes (Lond). 2006. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled … doi:10.1038/sj.ijo.0803283 PubMed
- [25] A A Nielsen et al.. Aliment Pharmacol Ther. 2005. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. doi:10.1111/j.1365-2036.2005.02698.x PubMed
- [26] Danielle Laurin et al.. J Alzheimers Dis. 2003. Omega-3 fatty acids and risk of cognitive impairment and dementia. doi:10.3233/jad-2003-5407 PubMed
- [27] R P Brown et al.. J Psychiatr Pract. 2001. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. doi:10.1097/00131746-200103000-00002 PubMed
- [28] T J Jeerakathil et al.. Curr Atheroscler Rep. 2001. Prevention of strokes. doi:10.1007/s11883-001-0026-7 PubMed
- [29] G Fernandes et al.. J Immunol. 1994. Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W … PubMed
- [30] J Vilaseca et al.. Gut. 1990. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. doi:10.1136/gut.31.5.539 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。